- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ 30.7462 ↓ -1.24%
[as on 13 February, 2026]
NAV chart
SMA (Simple Moving Average)
Returns
CAGR returns till date
CAGR returns of LIC MF Healthcare Fund-Direct Plan-Growth and its peers as on 13 February, 2026
| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|
| LIC MF Healthcare Fund-Direct Plan-Growth | -3.6% | -1.24% | 0.91% | -3.48% | -6.34% | 1.13% | - | - | - | - |
| SBI CONSUMPTION OPPORTUNITIES FUND - DIRECT PLAN - GROWTH | -3.44% | -1.05% | 0.6% | -1.55% | -4.72% | 1.29% | 13.92% | 16.69% | 16.2% | 16.86% |
| SBI ESG Exclusionary Strategy Fund - Direct Plan -Growth | -1.92% | -0.96% | -0.17% | -0.93% | -1.11% | 10.24% | 14.69% | 12.18% | 14.56% | 14.93% |
| SBI HEALTHCARE OPPORTUNITIES FUND - DIRECT PLAN -GROWTH | -0.71% | -1.01% | 1.53% | -0.77% | -3.47% | 3.79% | 25.54% | 16.87% | 21.41% | 13.46% |
| SBI INFRASTRUCTURE FUND - DIRECT PLAN - GROWTH | -1.43% | -1.21% | -0.35% | 1.76% | -1.33% | 8.93% | 22.39% | 21.1% | 21.08% | 18.32% |
| SBI PSU Fund - DIRECT PLAN - GROWTH | 5.59% | -1.19% | 1.43% | 5.81% | 6.15% | 30.1% | 35.14% | 29.88% | 23.35% | 18.01% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Returns | - | - | - | - | - | - | - | - | 44.27% | -3.64% |
Discrete returns (monthly)
| Month | Apr 2025 | May 2025 | Jun 2025 | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 |
|---|
| Returns | 0.84% | 0.64% | 3.36% | 4.19% | -1.22% | -0.19% | 2.1% | -0.36% | -1.86% | -6.27% |
Returns from spefic dates
| Description | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|
| Returns | -2.97% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|
| 97.11% |
0.00% (Arbitrage: 0.00%) |
0.00% |
0.00% |
2.90% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 10.39% |
| Apollo Hospitals Enterprise Ltd. | APOLLOHOSP (INE437A01024) | Healthcare Services | 5.90% |
| Cipla Ltd. | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 5.35% |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 5.34% |
| Fortis Healthcare Ltd. | FORTIS (INE061F01013) | Healthcare Services | 4.92% |
| Divi's Laboratories Ltd. | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 4.74% |
| Neuland Laboratories Ltd. | NEULANDLAB (INE794A01010) | Pharmaceuticals & Biotechnology | 4.54% |
| Piramal Pharma Ltd. | PPLPHARMA (INE0DK501011) | Pharmaceuticals & Biotechnology | 4.52% |
| Aurobindo Pharma Ltd. | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 4.07% |
| Alkem Laboratories Ltd. | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 3.91% |
| Onesource Specialty Pharma Ltd. | ONESOURCE (INE013P01021) | Pharmaceuticals & Biotechnology | 3.59% |
| Abbott India Ltd. | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 3.20% |
| Navin Fluorine International Ltd. | NAVINFLUOR (INE048G01026) | Chemicals & Petrochemicals | 3.11% |
| Artemis Medicare Services Ltd. | ARTEMISMED (INE025R01021) | Healthcare Services | 3.08% |
| Gland Pharma Ltd. | GLAND (INE068V01023) | Pharmaceuticals & Biotechnology | 2.94% |
| IPCA Laboratories Ltd. | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 2.66% |
| Glenmark Pharmaceuticals Ltd. | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 2.59% |
| Metropolis Healthcare Ltd. | METROPOLIS (INE112L01020) | Healthcare Services | 2.57% |
| Mankind Pharma Ltd. | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 2.33% |
| Dr Agarwal's Health Care Ltd. | AGARWALEYE (INE943P01029) | Healthcare Services | 2.29% |
| Global Health Ltd. | MEDANTA (INE474Q01031) | Healthcare Services | 2.24% |
| Max Healthcare Institute Ltd. | MAXHEALTH (INE027H01010) | Healthcare Services | 2.20% |
| Syngene International Ltd. | SYNGENE (INE398R01022) | Healthcare Services | 2.10% |
| Concord Biotech Ltd. | CONCORDBIO (INE338H01029) | Pharmaceuticals & Biotechnology | 2.03% |
| Acutaas Chemicals Ltd. | ACUTAAS (INE00FF01025) | Pharmaceuticals & Biotechnology | 1.92% |
| Anthem Biosciences Ltd. | ANTHEM (INE0CZ201020) | Pharmaceuticals & Biotechnology | 1.86% |
| Vinati Organics Ltd. | VINATIORGA (INE410B01037) | Chemicals & Petrochemicals | 1.65% |
| Linde India Ltd. | LINDEINDIA (INE473A01011) | Chemicals & Petrochemicals | 1.07% |
Portfolio data is as on date 31 October, 2025
NAV history
LIC MF Healthcare Fund-Direct Plan-Growth - 30 days NAV (Net asset value) history
| Date | NAV |
|---|
| 13 February, 2026 | 30.7462 |
| 12 February, 2026 | 31.133 |
| 11 February, 2026 | 31.1105 |
| 10 February, 2026 | 30.8874 |
| 9 February, 2026 | 30.9474 |
| 6 February, 2026 | 30.4678 |
| 5 February, 2026 | 30.4272 |
| 4 February, 2026 | 30.5025 |
| 3 February, 2026 | 30.5266 |
| 2 February, 2026 | 29.8921 |
| 30 January, 2026 | 30.0903 |
| 29 January, 2026 | 29.6241 |
| 28 January, 2026 | 29.8037 |
| 27 January, 2026 | 29.7426 |
| 23 January, 2026 | 30.0107 |
| 22 January, 2026 | 30.4874 |
| 21 January, 2026 | 30.2953 |
| 20 January, 2026 | 30.5267 |
| 19 January, 2026 | 31.2803 |
| 16 January, 2026 | 31.5514 |
| 14 January, 2026 | 31.8239 |
| 13 January, 2026 | 31.8537 |
| 12 January, 2026 | 31.8505 |
| 9 January, 2026 | 31.9239 |
| 8 January, 2026 | 32.2798 |
| 7 January, 2026 | 32.772 |
| 6 January, 2026 | 32.5111 |
| 5 January, 2026 | 32.1752 |
| 2 January, 2026 | 32.18 |
| 1 January, 2026 | 31.8933 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of LIC MF Healthcare Fund-Direct Plan-Growth?
The latest NAV of LIC MF Healthcare Fund-Direct Plan-Growth is 30.7462 as on 13 February, 2026.
What are YTD (year to date) returns of LIC MF Healthcare Fund-Direct Plan-Growth?
The YTD (year to date) returns of LIC MF Healthcare Fund-Direct Plan-Growth are -3.6% as on 13 February, 2026.
What are 1 year returns of LIC MF Healthcare Fund-Direct Plan-Growth?
The 1 year returns of LIC MF Healthcare Fund-Direct Plan-Growth are 1.13% as on 13 February, 2026.